How to Buy Solid Biosciences Stock
Solid Biosciences Inc
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States.
Solid Biosciences stock last closed at $3.31, up 8.52% from the previous day, and has decreased 62.68% in one year. It has overperformed other stocks in the Biotechnology industry by 0.14 percentage points. Solid Biosciences stock is currently +35.1% from its 52-week low of $2.45, and -69.88% from its 52-week high of $10.99.
As of Apr 30, 2025, there are 77.49M shares of SLDB outstanding. The market capitalization of SLDB is $256.50M. In the past 24 hours, 985,490 SLDB shares were traded.
How to Buy Solid Biosciences Stock
Not sure how to invest in Solid Biosciences stock? Here's how.
- Decide where to buy Solid Biosciences stock: You need to decide on an online brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you determine where to buy Solid Biosciences stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit funds into your brokerage account: Choose your payment method and add your details.
- Evaluate Solid Biosciences stock: The Solid Biosciences ticker symbol is SLDB. Is Solid Biosciences stock a good investment? Should you buy shares of SLDB? How do SLDB's underlying business fundamentals look? Do top analysts think Solid Biosciences is a good buy? Why has SLDB's stock price moved recently? (Hint: Our stock market research website can help you decide if SLDB is a good stock to buy).
- Execute your SLDB trade: Decide if you will purchase SLDB shares at the current market price or use a limit order to buy SLDB shares at a given price.
- Get updates on your SLDB investment: Create a watchlist to get the latest news on your investment in Solid Biosciences shares.
Step 1: Decide where to buy Solid Biosciences stock
You will need a brokerage account in order to access the NASDAQ market and buy SLDB shares.
Our recommended brokerage: eToro
In our opinion, eToro is the best brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global financial markets: From Technology to Financial Services, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've selected the best brokerage, it's time to fill out some personal information so you can invest in SLDB stock today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to start a new brokerage account.
- Send your information by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've finished signing up on the best stock market app for beginners, you can securely and quickly fund your account:
Watch the tutorial below to see the process of depositing money into your investment account.
Step 4: Evaluate Solid Biosciences stock
Once you have chosen the best place to buy Solid Biosciences stock, it's very important to analyze their stock before you buy, so you truly comprehend the risk and upside.
Overview of key SLDB info
Solid Biosciences Due Diligence Score
WallStreetZen was designed to help average investors do more in-depth fundamental analysis.
You can see all of the due diligence checks on SLDB's stock page.
Is SLDB stock undervalued or overvalued?
Analysts use many financial metrics, analyses, models, and charts to gauge SLDB's true value.
Using relative valuations ratios:
- SLDB may be undervalued based on its P/B ratio of 1.87x, relative to Biotechnology industry P/B ratio of 4.45x
You can do more valuation analysis on SLDB's stock here.
SLDB Financials at a glance
Passed Health Checks:
- SLDB has cash burn of 100661000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the SLDB balance sheet.
- There are more short-term assets than short-term liabilities on the SLDB balance sheet.
- SLDB has a low debt to equity ratio of 0.38.
Failed Health Checks:
- SLDB has $148.92M in cash and short term investments. This is not enough to cover its annual cash burn of $100.66M.
- Total SLDB debt is higher than 5 years ago, relative to shareholder equity.
Is Solid Biosciences stock a Buy, Hold, or Sell, according to analysts?
Out of 6 sell side analysts who monitor SLDB, the consensus analyst rating on SLDB is a Strong Buy
Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Most Recent SLDB Analyst Forecasts
Laura Chico, a top 33% analyst from Wedbush initiates coverage on SLDB with a buy rating and announces their SLDB price target of $16.00, on Dec 13, 2024.
You can dig deeper into what analysts are projecting on the Solid Biosciences stock forecast page.
SLDB Momentum
How is SLDB performing as a company?
Last year, SLDB revenue was $0.00. During the past three year, SLDB's revenue has increased by -100% per year. This was slower than the Biotechnology industry average of 45.66%.
Find out more about SLDB's earnings and revenue performance here.
Are SLDB insiders buying or selling the stock?
Over the last year, insiders at SLDB have bought more shares than they have sold.
Clare Kahn, Director of SLDB, was the latest SLDB insider to buy. They bought $9,924.96 worth of SLDB stock on Mar 11, 2025.
Learn more about who owns SLDB shares here.
Does SLDB provide a stable income stream?
No, Solid Biosciences doesn't provide an income stream by paying out dividends.
What others are saying about SLDB
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Execute your SLDB trade
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly the easiest way to buy. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a specific dollar amount limit, place a limit order.
Press the Open button and your broker will place the order.
If you want more help investing in stocks on eToro, click the how to video below:
Step 6: Get updates on your SLDB investment
Now that you own some shares in SLDB, you'll want to keep up with your new stock purchase.
Put SLDB on a watchlist to keep track of your SLDB stock.
SLDB Feed
How to Buy Stock in Solid Biosciences
To summarize, here are the 6 steps to buy stock in Solid Biosciences:
- Decide where to buy Solid Biosciences stock
- Sign up for your brokerage account
- Deposit funds into your brokerage account
- Evaluate Solid Biosciences stock
- Execute your SLDB trade
- Get updates on your SLDB investment
If you require a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to track your new investment in Solid Biosciences, click below.
Other Stock Buying Guides You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.